Drug profile · INN
hydroxyzine pamoate
HYDROXYZINE PAMOATE
hydroxyzine pamoate (HYDROXYZINE PAMOATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — hydroxyzine pamoate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
hydroxyzine pamoate (HYDROXYZINE PAMOATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is hydroxyzine pamoate?
hydroxyzine pamoate (HYDROXYZINE PAMOATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for hydroxyzine pamoate?
HYDROXYZINE PAMOATE is a marketed brand name for hydroxyzine pamoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydroxyzine pamoate?
hydroxyzine pamoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.